Pyrazolone-type compounds (part II): in vitro and in silico evaluation of antioxidant potential; structure-activity relationship
The pyrazolone class comprises a variety of hybrid compounds displaying diverse biological actions. Although studied for decades, these compounds are still of interest due to their facile chemical transformations. In our previous work, we presented the synthetic route of functionalised pyrazolone de...
Saved in:
| Published in: | RSC advances Vol. 13; no. 5; pp. 2884 - 2895 |
|---|---|
| Main Authors: | , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
Royal Society of Chemistry
18-01-2023
The Royal Society of Chemistry |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | The pyrazolone class comprises a variety of hybrid compounds displaying diverse biological actions. Although studied for decades, these compounds are still of interest due to their facile chemical transformations. In our previous work, we presented the synthetic route of functionalised pyrazolone derivatives. The presence of pyrazolone structural motif in many drugs, such as edaravone, prompted us to investigate the antioxidant features of the selected compounds. In this paper, we provide an extensive
and
description of the antioxidant properties of selected pyrazolone analogues. The obtained
results revealed their great antiradical potency against the DPPH radical (IC
values in the 2.6-7.8 μM range), where the best results were obtained for analogues bearing a catechol moiety. Density functional theory (DFT) was used to assess their antioxidant capacity from the thermodynamic aspect. Here, good agreement with
results was achieved. DFT was employed for the prediction of the most preferable radical scavenging pathway, also. In polar solvents, the SPLET mechanism is a favourable scavenging route, whereas in nonpolar solvents the HAT is slightly predominant. Furthermore, antioxidant mechanisms were studied in the presence of relevant reactive oxygen species. The obtained values of the reaction enthalpies with the selected radicals revealed that HAT is slightly prevailing in polar solvents, while the SPLET mechanism is dominant in nonpolar solvents. Regarding the well-known antioxidant features of the drug edaravone, these findings represent valuable data for this pyrazolone class and could be used as the basis for further investigations. |
|---|---|
| AbstractList | The pyrazolone class comprises a variety of hybrid compounds displaying diverse biological actions. Although studied for decades, these compounds are still of interest due to their facile chemical transformations. In our previous work, we presented the synthetic route of functionalised pyrazolone derivatives. The presence of pyrazolone structural motif in many drugs, such as edaravone, prompted us to investigate the antioxidant features of the selected compounds. In this paper, we provide an extensive
in vitro
and
in silico
description of the antioxidant properties of selected pyrazolone analogues. The obtained
in vitro
results revealed their great antiradical potency against the DPPH radical (IC
50
values in the 2.6–7.8 μM range), where the best results were obtained for analogues bearing a catechol moiety. Density functional theory (DFT) was used to assess their antioxidant capacity from the thermodynamic aspect. Here, good agreement with
in vitro
results was achieved. DFT was employed for the prediction of the most preferable radical scavenging pathway, also. In polar solvents, the SPLET mechanism is a favourable scavenging route, whereas in nonpolar solvents the HAT is slightly predominant. Furthermore, antioxidant mechanisms were studied in the presence of relevant reactive oxygen species. The obtained values of the reaction enthalpies with the selected radicals revealed that HAT is slightly prevailing in polar solvents, while the SPLET mechanism is dominant in nonpolar solvents. Regarding the well-known antioxidant features of the drug edaravone, these findings represent valuable data for this pyrazolone class and could be used as the basis for further investigations.
The pyrazolone class comprises a variety of hybrid compounds displaying diverse biological actions. The pyrazolone class comprises a variety of hybrid compounds displaying diverse biological actions. Although studied for decades, these compounds are still of interest due to their facile chemical transformations. In our previous work, we presented the synthetic route of functionalised pyrazolone derivatives. The presence of pyrazolone structural motif in many drugs, such as edaravone, prompted us to investigate the antioxidant features of the selected compounds. In this paper, we provide an extensive in vitro and in silico description of the antioxidant properties of selected pyrazolone analogues. The obtained in vitro results revealed their great antiradical potency against the DPPH radical (IC50 values in the 2.6-7.8 μM range), where the best results were obtained for analogues bearing a catechol moiety. Density functional theory (DFT) was used to assess their antioxidant capacity from the thermodynamic aspect. Here, good agreement with in vitro results was achieved. DFT was employed for the prediction of the most preferable radical scavenging pathway, also. In polar solvents, the SPLET mechanism is a favourable scavenging route, whereas in nonpolar solvents the HAT is slightly predominant. Furthermore, antioxidant mechanisms were studied in the presence of relevant reactive oxygen species. The obtained values of the reaction enthalpies with the selected radicals revealed that HAT is slightly prevailing in polar solvents, while the SPLET mechanism is dominant in nonpolar solvents. Regarding the well-known antioxidant features of the drug edaravone, these findings represent valuable data for this pyrazolone class and could be used as the basis for further investigations.The pyrazolone class comprises a variety of hybrid compounds displaying diverse biological actions. Although studied for decades, these compounds are still of interest due to their facile chemical transformations. In our previous work, we presented the synthetic route of functionalised pyrazolone derivatives. The presence of pyrazolone structural motif in many drugs, such as edaravone, prompted us to investigate the antioxidant features of the selected compounds. In this paper, we provide an extensive in vitro and in silico description of the antioxidant properties of selected pyrazolone analogues. The obtained in vitro results revealed their great antiradical potency against the DPPH radical (IC50 values in the 2.6-7.8 μM range), where the best results were obtained for analogues bearing a catechol moiety. Density functional theory (DFT) was used to assess their antioxidant capacity from the thermodynamic aspect. Here, good agreement with in vitro results was achieved. DFT was employed for the prediction of the most preferable radical scavenging pathway, also. In polar solvents, the SPLET mechanism is a favourable scavenging route, whereas in nonpolar solvents the HAT is slightly predominant. Furthermore, antioxidant mechanisms were studied in the presence of relevant reactive oxygen species. The obtained values of the reaction enthalpies with the selected radicals revealed that HAT is slightly prevailing in polar solvents, while the SPLET mechanism is dominant in nonpolar solvents. Regarding the well-known antioxidant features of the drug edaravone, these findings represent valuable data for this pyrazolone class and could be used as the basis for further investigations. The pyrazolone class comprises a variety of hybrid compounds displaying diverse biological actions. Although studied for decades, these compounds are still of interest due to their facile chemical transformations. In our previous work, we presented the synthetic route of functionalised pyrazolone derivatives. The presence of pyrazolone structural motif in many drugs, such as edaravone, prompted us to investigate the antioxidant features of the selected compounds. In this paper, we provide an extensive and description of the antioxidant properties of selected pyrazolone analogues. The obtained results revealed their great antiradical potency against the DPPH radical (IC values in the 2.6-7.8 μM range), where the best results were obtained for analogues bearing a catechol moiety. Density functional theory (DFT) was used to assess their antioxidant capacity from the thermodynamic aspect. Here, good agreement with results was achieved. DFT was employed for the prediction of the most preferable radical scavenging pathway, also. In polar solvents, the SPLET mechanism is a favourable scavenging route, whereas in nonpolar solvents the HAT is slightly predominant. Furthermore, antioxidant mechanisms were studied in the presence of relevant reactive oxygen species. The obtained values of the reaction enthalpies with the selected radicals revealed that HAT is slightly prevailing in polar solvents, while the SPLET mechanism is dominant in nonpolar solvents. Regarding the well-known antioxidant features of the drug edaravone, these findings represent valuable data for this pyrazolone class and could be used as the basis for further investigations. The pyrazolone class comprises a variety of hybrid compounds displaying diverse biological actions. Although studied for decades, these compounds are still of interest due to their facile chemical transformations. In our previous work, we presented the synthetic route of functionalised pyrazolone derivatives. The presence of pyrazolone structural motif in many drugs, such as edaravone, prompted us to investigate the antioxidant features of the selected compounds. In this paper, we provide an extensive in vitro and in silico description of the antioxidant properties of selected pyrazolone analogues. The obtained in vitro results revealed their great antiradical potency against the DPPH radical (IC50 values in the 2.6–7.8 μM range), where the best results were obtained for analogues bearing a catechol moiety. Density functional theory (DFT) was used to assess their antioxidant capacity from the thermodynamic aspect. Here, good agreement with in vitro results was achieved. DFT was employed for the prediction of the most preferable radical scavenging pathway, also. In polar solvents, the SPLET mechanism is a favourable scavenging route, whereas in nonpolar solvents the HAT is slightly predominant. Furthermore, antioxidant mechanisms were studied in the presence of relevant reactive oxygen species. The obtained values of the reaction enthalpies with the selected radicals revealed that HAT is slightly prevailing in polar solvents, while the SPLET mechanism is dominant in nonpolar solvents. Regarding the well-known antioxidant features of the drug edaravone, these findings represent valuable data for this pyrazolone class and could be used as the basis for further investigations. The pyrazolone class comprises a variety of hybrid compounds displaying diverse biological actions. Although studied for decades, these compounds are still of interest due to their facile chemical transformations. In our previous work, we presented the synthetic route of functionalised pyrazolone derivatives. The presence of pyrazolone structural motif in many drugs, such as edaravone, prompted us to investigate the antioxidant features of the selected compounds. In this paper, we provide an extensive in vitro and in silico description of the antioxidant properties of selected pyrazolone analogues. The obtained in vitro results revealed their great antiradical potency against the DPPH radical (IC 50 values in the 2.6–7.8 μM range), where the best results were obtained for analogues bearing a catechol moiety. Density functional theory (DFT) was used to assess their antioxidant capacity from the thermodynamic aspect. Here, good agreement with in vitro results was achieved. DFT was employed for the prediction of the most preferable radical scavenging pathway, also. In polar solvents, the SPLET mechanism is a favourable scavenging route, whereas in nonpolar solvents the HAT is slightly predominant. Furthermore, antioxidant mechanisms were studied in the presence of relevant reactive oxygen species. The obtained values of the reaction enthalpies with the selected radicals revealed that HAT is slightly prevailing in polar solvents, while the SPLET mechanism is dominant in nonpolar solvents. Regarding the well-known antioxidant features of the drug edaravone, these findings represent valuable data for this pyrazolone class and could be used as the basis for further investigations. |
| Author | Petrović, Zorica D Branković, Jovica Petrović, Vladimir P Milovanović, Vesna M Simijonović, Dušica |
| Author_xml | – sequence: 1 givenname: Jovica orcidid: 0000-0003-1635-4519 surname: Branković fullname: Branković, Jovica email: vladimir.petrovic@pmf.kg.ac.rs organization: University of Kragujevac, Faculty of Science, Department of Chemistry R. Domanovića 12 34000 Kragujevac Serbia vladimir.petrovic@pmf.kg.ac.rs – sequence: 2 givenname: Vesna M orcidid: 0000-0002-4297-7042 surname: Milovanović fullname: Milovanović, Vesna M organization: University of Kragujevac, Faculty of Agronomy, Department of Chemistry and Chemical Engineering Cara Dušana 34 32000 Čačak Serbia – sequence: 3 givenname: Zorica D orcidid: 0000-0003-0451-2006 surname: Petrović fullname: Petrović, Zorica D email: vladimir.petrovic@pmf.kg.ac.rs organization: University of Kragujevac, Faculty of Science, Department of Chemistry R. Domanovića 12 34000 Kragujevac Serbia vladimir.petrovic@pmf.kg.ac.rs – sequence: 4 givenname: Dušica orcidid: 0000-0002-3799-653X surname: Simijonović fullname: Simijonović, Dušica organization: University of Kragujevac, Institute for Information Technologies, Department of Science Jovana Cvijića bb 34000 Kragujevac Serbia – sequence: 5 givenname: Vladimir P orcidid: 0000-0002-1904-368X surname: Petrović fullname: Petrović, Vladimir P email: vladimir.petrovic@pmf.kg.ac.rs organization: University of Kragujevac, Faculty of Science, Department of Chemistry R. Domanovića 12 34000 Kragujevac Serbia vladimir.petrovic@pmf.kg.ac.rs |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36756409$$D View this record in MEDLINE/PubMed |
| BookMark | eNpdkVtrFTEUhYO02It98QdIoC9VmJpkMpmkgtDWag8UFNHnkEkybUpOMiaZQ0-f_OmmF0s1L3tv9pfF2qwdsBFisAC8xugQo1a8NyQpxAlHwwuwTRBlDUFMbDzrt8BezteoPtZhwvBLsNWyvmMUiW3w-9s6qdvoq2hT1pOFOi6nOAeT4cGkUoGLxdsj6AJcuZIiVMHcDdl5pyO0K-VnVVwMMI51V7sbZ2qFUyy2jsp_gLmkWZc52Ubp4qrMGibr73_lKze9Apuj8tnuPdZd8PPz2Y_T8-bi65fF6fFFoylipWk5HTozCNPzkXWU6YFyY7kynI_G2pZjRIYRoY72uGMM4QFzoxWq92Ir-NDugo8PutM8LK3R1V5SXk7JLVVay6ic_HcT3JW8jCspOGU95lXg4FEgxV-zzUUuXdbWexVsnLMkfU-5oLwVFd3_D72Ocwr1vEox0YmeUFKpdw-UTjHnZMcnMxjJu2zlJ_L9-D7bkwq_eW7_Cf2bZPsH6TejlA |
| CitedBy_id | crossref_primary_10_3390_computation11050088 crossref_primary_10_1007_s11172_023_4053_1 crossref_primary_10_1016_j_bmcl_2023_129479 |
| Cites_doi | 10.4172/2161-0444.1000127 10.1002/jccs.202100357 10.1039/C5RA16236J 10.1111/j.1527-3458.2006.00009.x 10.1039/D2RA02542F 10.1016/j.molstruc.2022.133044 10.1016/j.compbiolchem.2016.09.013 10.1111/cbdd.12712 10.1016/j.cej.2020.124971 10.1016/j.jsps.2011.01.003 10.1002/0470015535.ch11 10.1016/j.pediatrneurol.2010.05.009 10.1016/j.ejmech.2013.10.068 10.1016/j.poly.2013.08.051 10.2478/acph-2021-0040 10.1080/17518253.2014.894142 10.1007/s00044-013-0636-y 10.1021/jo7024543 10.1186/s42269-020-00391-z 10.1021/jo020184v 10.1007/s12039-021-01943-0 10.1039/C7CP01716B 10.1186/s13065-021-00765-y 10.1016/j.cdc.2018.11.004 10.1016/j.ejmech.2018.09.052 10.1007/s13738-019-01618-1 10.3390/antiox8120590 10.1002/ardp.201600019 10.1016/j.bmcl.2010.08.057 10.1063/1.464913 10.1016/j.molstruc.2021.132319 10.1016/j.jscs.2017.12.003 10.1039/C4RA07584F 10.1016/j.bioorg.2018.02.002 10.1016/j.cclet.2015.07.027 10.1016/j.jscs.2011.12.014 10.1002/ejoc.201601485 10.1016/j.bbrc.2004.06.094 10.1016/j.comptc.2015.09.007 10.1021/jm101208x 10.1021/ja020757l 10.1103/PhysRevB.37.785 10.1016/j.foodchem.2006.07.026 10.1007/s11164-016-2728-z 10.1016/j.bmc.2020.115463 10.1080/23312009.2016.1141388 10.1042/BSR20201950 10.1007/s11164-014-1896-y 10.1007/s10593-015-1656-y 10.1021/jp809094y 10.1039/c1md00041a 10.1002/ddr.21711 10.5504/BBEQ.2012.0135 10.1021/ic502274b 10.1016/j.tetlet.2014.05.131 10.31782/IJCRR.2020.122329 10.1007/s11164-018-3521-y 10.1080/14756366.2020.1801673 10.1155/2017/7943051 10.1002/9780470638859 10.1016/j.bmcl.2018.01.043 10.1016/j.molstruc.2022.133105 10.1016/j.bioorg.2014.02.002 10.1111/cbdd.14030 10.1016/j.bmcl.2006.03.043 10.1007/s00044-020-02667-5 10.1080/1475636031000069291 10.1016/j.molstruc.2021.130665 10.1007/s11030-015-9568-4 10.1063/1.456153 10.1016/j.ejmech.2019.111893 10.1016/j.ejmech.2013.05.040 10.1039/C5RA02134K 10.1016/j.bmc.2014.02.042 10.1021/acs.jafc.5b03839 10.1016/j.theochem.2008.01.014 10.1021/jf500180u |
| ContentType | Journal Article |
| Copyright | This journal is © The Royal Society of Chemistry. Copyright Royal Society of Chemistry 2023 This journal is © The Royal Society of Chemistry 2023 The Royal Society of Chemistry |
| Copyright_xml | – notice: This journal is © The Royal Society of Chemistry. – notice: Copyright Royal Society of Chemistry 2023 – notice: This journal is © The Royal Society of Chemistry 2023 The Royal Society of Chemistry |
| DBID | NPM AAYXX CITATION 7SR 8BQ 8FD JG9 7X8 5PM |
| DOI | 10.1039/d2ra08280b |
| DatabaseName | PubMed CrossRef Engineered Materials Abstracts METADEX Technology Research Database Materials Research Database MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | PubMed CrossRef Materials Research Database Engineered Materials Abstracts Technology Research Database METADEX MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed Materials Research Database CrossRef |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Chemistry |
| EISSN | 2046-2069 |
| EndPage | 2895 |
| ExternalDocumentID | 10_1039_D2RA08280B 36756409 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: ; grantid: 451-03-68/2022-14/200122, 451-03-68/2022-14/200088, 451-03-68/2022-14/200378 |
| GroupedDBID | -JG 0-7 0R~ 53G AAFWJ AAHBH AAIWI AAJAE AARTK AAWGC AAXHV ABEMK ABGFH ABPDG ABXOH ACGFS ADBBV ADMRA AEFDR AENEX AESAV AFLYV AFVBQ AGEGJ AGRSR AGSTE AHGCF AKBGW ALMA_UNASSIGNED_HOLDINGS ANUXI APEMP ASKNT AUDPV BCNDV BLAPV BSQNT C6K EBS EE0 EF- GROUPED_DOAJ H13 HZ~ H~N J3I M~E NPM O9- OK1 PGMZT R7C R7G RCNCU RPM RPMJG RRC RSCEA RVUXY SLH SMJ ZCN AAYXX CITATION 7SR 8BQ 8FD JG9 7X8 5PM AFPKN |
| ID | FETCH-LOGICAL-c406t-384b5db9d78f6546cb48de8ad88fdee38102bf00547156601b18dca02611e98b3 |
| IEDL.DBID | RPM |
| ISSN | 2046-2069 |
| IngestDate | Tue Sep 17 21:30:32 EDT 2024 Sat Oct 26 04:00:04 EDT 2024 Thu Oct 10 20:16:02 EDT 2024 Thu Nov 21 22:25:43 EST 2024 Sat Nov 02 12:26:14 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Language | English |
| License | This journal is © The Royal Society of Chemistry. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c406t-384b5db9d78f6546cb48de8ad88fdee38102bf00547156601b18dca02611e98b3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-4297-7042 0000-0003-0451-2006 0000-0002-3799-653X 0000-0002-1904-368X 0000-0003-1635-4519 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846718/ |
| PMID | 36756409 |
| PQID | 2769597242 |
| PQPubID | 2047525 |
| PageCount | 12 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_9846718 proquest_miscellaneous_2774894839 proquest_journals_2769597242 crossref_primary_10_1039_D2RA08280B pubmed_primary_36756409 |
| PublicationCentury | 2000 |
| PublicationDate | 2023-01-18 |
| PublicationDateYYYYMMDD | 2023-01-18 |
| PublicationDate_xml | – month: 01 year: 2023 text: 2023-01-18 day: 18 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Cambridge |
| PublicationTitle | RSC advances |
| PublicationTitleAlternate | RSC Adv |
| PublicationYear | 2023 |
| Publisher | Royal Society of Chemistry The Royal Society of Chemistry |
| Publisher_xml | – name: Royal Society of Chemistry – name: The Royal Society of Chemistry |
| References | Yousuf (D2RA08280B/cit33/1) 2018; 159 Indrasena (D2RA08280B/cit8/1) 2014; 55 Khaligh (D2RA08280B/cit52/1) 2016; 27 Kontogiorgis (D2RA08280B/cit74/1) 2003; 18 Shubhalaxmi (D2RA08280B/cit9/1) 2016; 2 Atatreh (D2RA08280B/cit26/1) 2021; 71 Becke (D2RA08280B/cit79/1) 1993; 98 Dunning (D2RA08280B/cit80/1) 1989; 90 Zhou (D2RA08280B/cit51/1) 2014; 7 Barajas-Carrillo (D2RA08280B/cit59/1) 2021; 30 Idemudia (D2RA08280B/cit60/1) 2017; 2017 Ashtekar (D2RA08280B/cit38/1) 2022 Xie (D2RA08280B/cit71/1) 2014; 62 Mustafa (D2RA08280B/cit2/1) 2022; 1262 Vafaee (D2RA08280B/cit48/1) 2015; 41 Kang (D2RA08280B/cit58/1) 2015; 19 Marković (D2RA08280B/cit83/1) 2016; 1077 Jain (D2RA08280B/cit56/1) 2021; 133 Nikolova (D2RA08280B/cit6/1) 2013; 27 Bailly (D2RA08280B/cit39/1) 2020; 28 Parr (D2RA08280B/cit72/1) 1984; 106 Dohutia (D2RA08280B/cit22/1) 2013; 5 Amić (D2RA08280B/cit70/1) 2016; 65 El Sayed (D2RA08280B/cit19/1) 2018; 28 Antre (D2RA08280B/cit20/1) 2012; 02 Obakachi (D2RA08280B/cit25/1) 2021; 1241 Messaad (D2RA08280B/cit32/1) 2022; 1263 Anwar (D2RA08280B/cit28/1) 2020; 81 Cadena-Cruz (D2RA08280B/cit27/1) 2021; 15 Vyas (D2RA08280B/cit15/1) 2013; 65 Mariappan (D2RA08280B/cit18/1) 2011; 19 Priya (D2RA08280B/cit57/1) 2020; 12 Adhikari (D2RA08280B/cit7/1) 2021; 11 Shamsuzzaman (D2RA08280B/cit12/1) 2014; 23 Kadam (D2RA08280B/cit3/1) 2014; 53 Chaudhry (D2RA08280B/cit34/1) 2018; 77 Zarghani (D2RA08280B/cit45/1) 2015; 5 Kakiuchi (D2RA08280B/cit37/1) 2004; 320 Zhao (D2RA08280B/cit4/1) 2020; 186 Khalil (D2RA08280B/cit17/1) 2014; 22 Walker (D2RA08280B/cit43/1) 2011; 2 Torres de Pinedo (D2RA08280B/cit62/1) 2007; 103 Ramesh (D2RA08280B/cit49/1) 2017; 43 Foti (D2RA08280B/cit76/1) 2015; 63 Dahal (D2RA08280B/cit14/1) 2022; 99 Kulkarni (D2RA08280B/cit35/1) 2018; 17–18 Foti (D2RA08280B/cit63/1) 2002; 67 Krishnasamy (D2RA08280B/cit13/1) 2016; 349 Capaldo (D2RA08280B/cit68/1) 2017; 2017 Perrone (D2RA08280B/cit41/1) 2010; 43 Lee (D2RA08280B/cit78/1) 1988; 37 Safaei-Ghomi (D2RA08280B/cit47/1) 2015; 51 Çınar (D2RA08280B/cit31/1) 2021; 68 Zondagh (D2RA08280B/cit40/1) 2020; 35 Orabi (D2RA08280B/cit29/1) 2018; 22 Hadi (D2RA08280B/cit36/1) 2010; 20 Miliovsky (D2RA08280B/cit54/1) 2013; 66 Petrović (D2RA08280B/cit82/1) 2015; 5 Uramaru (D2RA08280B/cit23/1) 2010; 53 Zhang (D2RA08280B/cit30/1) 2022; 1254 Dimić (D2RA08280B/cit75/1) 2017; 19 Al-Saheb (D2RA08280B/cit10/1) 2020; 40 Sadjadi (D2RA08280B/cit50/1) 2018; 44 Zhou (D2RA08280B/cit67/1) 2019; 8 Antonczak (D2RA08280B/cit66/1) 2008; 856 Alisi (D2RA08280B/cit69/1) 2020; 44 Moneer (D2RA08280B/cit21/1) 2016; 87 Valgimigli (D2RA08280B/cit61/1) 2008; 73 Milenković (D2RA08280B/cit73/1) 2020; 395 Safaei-Ghomi (D2RA08280B/cit46/1) 2014; 4 Pettinari (D2RA08280B/cit16/1) 2014; 53 Yoshida (D2RA08280B/cit42/1) 2006; 12 Foti (D2RA08280B/cit64/1) 2002; 124 Sneader (D2RA08280B/cit5/1) 2006 Parmar (D2RA08280B/cit11/1) 2015; 19 Branković (D2RA08280B/cit44/1) 2022; 12 Wang (D2RA08280B/cit1/1) 2010 Fan (D2RA08280B/cit24/1) 2006; 16 Li (D2RA08280B/cit55/1) 2014; 71 Lee (D2RA08280B/cit65/1) 2020; 9 Mohammadi Ziarani (D2RA08280B/cit53/1) 2019; 16 Marenich (D2RA08280B/cit81/1) 2009; 113 |
| References_xml | – volume: 02 start-page: 126 year: 2012 ident: D2RA08280B/cit20/1 publication-title: Med. Chem. doi: 10.4172/2161-0444.1000127 contributor: fullname: Antre – volume: 68 start-page: 2355 year: 2021 ident: D2RA08280B/cit31/1 publication-title: J. Chin. Chem. Soc. doi: 10.1002/jccs.202100357 contributor: fullname: Çınar – volume: 5 start-page: 87769 year: 2015 ident: D2RA08280B/cit45/1 publication-title: RSC Adv. doi: 10.1039/C5RA16236J contributor: fullname: Zarghani – volume: 12 start-page: 9 year: 2006 ident: D2RA08280B/cit42/1 publication-title: CNS Drug Rev. doi: 10.1111/j.1527-3458.2006.00009.x contributor: fullname: Yoshida – volume: 12 start-page: 16054 year: 2022 ident: D2RA08280B/cit44/1 publication-title: RSC Adv. doi: 10.1039/D2RA02542F contributor: fullname: Branković – volume: 1262 start-page: 133044 year: 2022 ident: D2RA08280B/cit2/1 publication-title: J. Mol. Struct. doi: 10.1016/j.molstruc.2022.133044 contributor: fullname: Mustafa – volume: 65 start-page: 45 year: 2016 ident: D2RA08280B/cit70/1 publication-title: Comput. Biol. Chem. doi: 10.1016/j.compbiolchem.2016.09.013 contributor: fullname: Amić – volume: 87 start-page: 784 year: 2016 ident: D2RA08280B/cit21/1 publication-title: Chem. Biol. Drug Des. doi: 10.1111/cbdd.12712 contributor: fullname: Moneer – volume: 395 start-page: 124971 year: 2020 ident: D2RA08280B/cit73/1 publication-title: Chem. Eng. J. doi: 10.1016/j.cej.2020.124971 contributor: fullname: Milenković – volume: 19 start-page: 115 year: 2011 ident: D2RA08280B/cit18/1 publication-title: Saudi Pharmaceut. J. doi: 10.1016/j.jsps.2011.01.003 contributor: fullname: Mariappan – year: 2022 ident: D2RA08280B/cit38/1 publication-title: Res. Square contributor: fullname: Ashtekar – start-page: 115 volume-title: Drug Discovery year: 2006 ident: D2RA08280B/cit5/1 doi: 10.1002/0470015535.ch11 contributor: fullname: Sneader – volume: 43 start-page: 236 year: 2010 ident: D2RA08280B/cit41/1 publication-title: Pediatr. Neurol. doi: 10.1016/j.pediatrneurol.2010.05.009 contributor: fullname: Perrone – volume: 71 start-page: 36 year: 2014 ident: D2RA08280B/cit55/1 publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2013.10.068 contributor: fullname: Li – volume: 65 start-page: 262 year: 2013 ident: D2RA08280B/cit15/1 publication-title: Polyhedron doi: 10.1016/j.poly.2013.08.051 contributor: fullname: Vyas – volume: 71 start-page: 325 year: 2021 ident: D2RA08280B/cit26/1 publication-title: Acta Pharm. doi: 10.2478/acph-2021-0040 contributor: fullname: Atatreh – volume: 7 start-page: 18 year: 2014 ident: D2RA08280B/cit51/1 publication-title: Green Chem. Lett. Rev. doi: 10.1080/17518253.2014.894142 contributor: fullname: Zhou – volume: 23 start-page: 348 year: 2014 ident: D2RA08280B/cit12/1 publication-title: Med. Chem. Res. doi: 10.1007/s00044-013-0636-y contributor: fullname: Shamsuzzaman – volume: 9 start-page: 1 year: 2020 ident: D2RA08280B/cit65/1 publication-title: Antioxidants contributor: fullname: Lee – volume: 73 start-page: 1830 year: 2008 ident: D2RA08280B/cit61/1 publication-title: J. Org. Chem. doi: 10.1021/jo7024543 contributor: fullname: Valgimigli – volume: 44 start-page: 137 year: 2020 ident: D2RA08280B/cit69/1 publication-title: Bull. Natl. Res. Cent. doi: 10.1186/s42269-020-00391-z contributor: fullname: Alisi – volume: 67 start-page: 5190 year: 2002 ident: D2RA08280B/cit63/1 publication-title: J. Org. Chem. doi: 10.1021/jo020184v contributor: fullname: Foti – volume: 133 start-page: 1 year: 2021 ident: D2RA08280B/cit56/1 publication-title: J. Chem. Sci. doi: 10.1007/s12039-021-01943-0 contributor: fullname: Jain – volume: 19 start-page: 12970 year: 2017 ident: D2RA08280B/cit75/1 publication-title: Phys. Chem. Chem. Phys. doi: 10.1039/C7CP01716B contributor: fullname: Dimić – volume: 15 start-page: 38 year: 2021 ident: D2RA08280B/cit27/1 publication-title: BMC Chem. doi: 10.1186/s13065-021-00765-y contributor: fullname: Cadena-Cruz – volume: 17–18 start-page: 497 year: 2018 ident: D2RA08280B/cit35/1 publication-title: Chem. Data Collect. doi: 10.1016/j.cdc.2018.11.004 contributor: fullname: Kulkarni – volume: 159 start-page: 47 year: 2018 ident: D2RA08280B/cit33/1 publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2018.09.052 contributor: fullname: Yousuf – volume: 16 start-page: 1401 year: 2019 ident: D2RA08280B/cit53/1 publication-title: J. Iran. Chem. Soc. doi: 10.1007/s13738-019-01618-1 contributor: fullname: Mohammadi Ziarani – volume: 8 start-page: 590 year: 2019 ident: D2RA08280B/cit67/1 publication-title: Antioxidants doi: 10.3390/antiox8120590 contributor: fullname: Zhou – volume: 349 start-page: 383 year: 2016 ident: D2RA08280B/cit13/1 publication-title: Arch. Pharm. doi: 10.1002/ardp.201600019 contributor: fullname: Krishnasamy – volume: 20 start-page: 6854 year: 2010 ident: D2RA08280B/cit36/1 publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2010.08.057 contributor: fullname: Hadi – volume: 98 start-page: 5648 year: 1993 ident: D2RA08280B/cit79/1 publication-title: J. Chem. Phys. doi: 10.1063/1.464913 contributor: fullname: Becke – volume: 1254 start-page: 132319 year: 2022 ident: D2RA08280B/cit30/1 publication-title: J. Mol. Struct. doi: 10.1016/j.molstruc.2021.132319 contributor: fullname: Zhang – volume: 22 start-page: 705 year: 2018 ident: D2RA08280B/cit29/1 publication-title: J. Saudi Chem. Soc. doi: 10.1016/j.jscs.2017.12.003 contributor: fullname: Orabi – volume: 4 start-page: 46106 year: 2014 ident: D2RA08280B/cit46/1 publication-title: RSC Adv. doi: 10.1039/C4RA07584F contributor: fullname: Safaei-Ghomi – volume: 77 start-page: 507 year: 2018 ident: D2RA08280B/cit34/1 publication-title: Bioorg. Chem. doi: 10.1016/j.bioorg.2018.02.002 contributor: fullname: Chaudhry – volume: 27 start-page: 104 year: 2016 ident: D2RA08280B/cit52/1 publication-title: Chin. Chem. Lett. doi: 10.1016/j.cclet.2015.07.027 contributor: fullname: Khaligh – volume: 19 start-page: 36 year: 2015 ident: D2RA08280B/cit11/1 publication-title: J. Saudi Chem. Soc. doi: 10.1016/j.jscs.2011.12.014 contributor: fullname: Parmar – volume: 2017 start-page: 2056 year: 2017 ident: D2RA08280B/cit68/1 publication-title: Eur. J. Org. Chem. doi: 10.1002/ejoc.201601485 contributor: fullname: Capaldo – volume: 320 start-page: 1351 year: 2004 ident: D2RA08280B/cit37/1 publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2004.06.094 contributor: fullname: Kakiuchi – volume: 1077 start-page: 11 year: 2016 ident: D2RA08280B/cit83/1 publication-title: Comput. Theor. Chem. doi: 10.1016/j.comptc.2015.09.007 contributor: fullname: Marković – volume: 53 start-page: 8727 year: 2010 ident: D2RA08280B/cit23/1 publication-title: J. Med. Chem. doi: 10.1021/jm101208x contributor: fullname: Uramaru – volume: 124 start-page: 12881 year: 2002 ident: D2RA08280B/cit64/1 publication-title: J. Am. Chem. Soc. doi: 10.1021/ja020757l contributor: fullname: Foti – volume: 37 start-page: 785 year: 1988 ident: D2RA08280B/cit78/1 publication-title: Phys. Rev. B: Condens. Matter Mater. Phys. doi: 10.1103/PhysRevB.37.785 contributor: fullname: Lee – volume: 103 start-page: 55 year: 2007 ident: D2RA08280B/cit62/1 publication-title: Food Chem. doi: 10.1016/j.foodchem.2006.07.026 contributor: fullname: Torres de Pinedo – volume: 43 start-page: 1767 year: 2017 ident: D2RA08280B/cit49/1 publication-title: Res. Chem. Intermed. doi: 10.1007/s11164-016-2728-z contributor: fullname: Ramesh – volume: 28 start-page: 115463 year: 2020 ident: D2RA08280B/cit39/1 publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2020.115463 contributor: fullname: Bailly – volume: 2 start-page: 1141388 year: 2016 ident: D2RA08280B/cit9/1 publication-title: Cogent Chem. doi: 10.1080/23312009.2016.1141388 contributor: fullname: Shubhalaxmi – volume: 11 start-page: 26 year: 2021 ident: D2RA08280B/cit7/1 publication-title: J. Appl. Pharm. Sci. contributor: fullname: Adhikari – volume: 40 start-page: 1 year: 2020 ident: D2RA08280B/cit10/1 publication-title: Biosci. Rep. doi: 10.1042/BSR20201950 contributor: fullname: Al-Saheb – volume: 41 start-page: 8343 year: 2015 ident: D2RA08280B/cit48/1 publication-title: Res. Chem. Intermed. doi: 10.1007/s11164-014-1896-y contributor: fullname: Vafaee – volume: 51 start-page: 34 year: 2015 ident: D2RA08280B/cit47/1 publication-title: Chem. Heterocycl. Compd. doi: 10.1007/s10593-015-1656-y contributor: fullname: Safaei-Ghomi – volume: 113 start-page: 4538 year: 2009 ident: D2RA08280B/cit81/1 publication-title: J. Phys. Chem. B doi: 10.1021/jp809094y contributor: fullname: Marenich – volume: 2 start-page: 436 year: 2011 ident: D2RA08280B/cit43/1 publication-title: Medchemcomm doi: 10.1039/c1md00041a contributor: fullname: Walker – volume: 81 start-page: 893 year: 2020 ident: D2RA08280B/cit28/1 publication-title: Drug Dev. Res. doi: 10.1002/ddr.21711 contributor: fullname: Anwar – volume: 27 start-page: 3605 year: 2013 ident: D2RA08280B/cit6/1 publication-title: Biotechnol. Biotechnol. Equip. doi: 10.5504/BBEQ.2012.0135 contributor: fullname: Nikolova – volume: 53 start-page: 13105 year: 2014 ident: D2RA08280B/cit16/1 publication-title: Inorg. Chem. doi: 10.1021/ic502274b contributor: fullname: Pettinari – volume: 55 start-page: 5014 year: 2014 ident: D2RA08280B/cit8/1 publication-title: Tetrahedron Lett. doi: 10.1016/j.tetlet.2014.05.131 contributor: fullname: Indrasena – volume: 12 start-page: 68 issue: 23 year: 2020 ident: D2RA08280B/cit57/1 publication-title: Int. J. Curr. Res. Rev. doi: 10.31782/IJCRR.2020.122329 contributor: fullname: Priya – volume: 44 start-page: 6765 year: 2018 ident: D2RA08280B/cit50/1 publication-title: Res. Chem. Intermed. doi: 10.1007/s11164-018-3521-y contributor: fullname: Sadjadi – volume: 35 start-page: 1596 year: 2020 ident: D2RA08280B/cit40/1 publication-title: J. Enzyme Inhib. Med. Chem. doi: 10.1080/14756366.2020.1801673 contributor: fullname: Zondagh – volume: 2017 start-page: 1 year: 2017 ident: D2RA08280B/cit60/1 publication-title: J. Chem. doi: 10.1155/2017/7943051 contributor: fullname: Idemudia – volume: 5 start-page: 86 year: 2013 ident: D2RA08280B/cit22/1 publication-title: Int. J. Pharm. Sci. contributor: fullname: Dohutia – start-page: 331 volume-title: Comprehensive Organic Name Reactions and Reagents year: 2010 ident: D2RA08280B/cit1/1 doi: 10.1002/9780470638859 contributor: fullname: Wang – volume: 28 start-page: 952 year: 2018 ident: D2RA08280B/cit19/1 publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2018.01.043 contributor: fullname: El Sayed – volume: 1263 start-page: 133105 year: 2022 ident: D2RA08280B/cit32/1 publication-title: J. Mol. Struct. doi: 10.1016/j.molstruc.2022.133105 contributor: fullname: Messaad – volume: 53 start-page: 67 year: 2014 ident: D2RA08280B/cit3/1 publication-title: Bioorg. Chem. doi: 10.1016/j.bioorg.2014.02.002 contributor: fullname: Kadam – volume: 99 start-page: 620 year: 2022 ident: D2RA08280B/cit14/1 publication-title: Chem. Biol. Drug Des. doi: 10.1111/cbdd.14030 contributor: fullname: Dahal – volume: 16 start-page: 3224 year: 2006 ident: D2RA08280B/cit24/1 publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2006.03.043 contributor: fullname: Fan – volume: 30 start-page: 610 year: 2021 ident: D2RA08280B/cit59/1 publication-title: Med. Chem. Res. doi: 10.1007/s00044-020-02667-5 contributor: fullname: Barajas-Carrillo – volume: 18 start-page: 63 year: 2003 ident: D2RA08280B/cit74/1 publication-title: J. Enzyme Inhib. Med. Chem. doi: 10.1080/1475636031000069291 contributor: fullname: Kontogiorgis – volume: 1241 start-page: 130665 year: 2021 ident: D2RA08280B/cit25/1 publication-title: J. Mol. Struct. doi: 10.1016/j.molstruc.2021.130665 contributor: fullname: Obakachi – volume: 19 start-page: 293 year: 2015 ident: D2RA08280B/cit58/1 publication-title: Mol. Divers. doi: 10.1007/s11030-015-9568-4 contributor: fullname: Kang – volume: 90 start-page: 1007 year: 1989 ident: D2RA08280B/cit80/1 publication-title: J. Chem. Phys. doi: 10.1063/1.456153 contributor: fullname: Dunning – volume: 186 start-page: 111893 year: 2020 ident: D2RA08280B/cit4/1 publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2019.111893 contributor: fullname: Zhao – volume: 66 start-page: 185 year: 2013 ident: D2RA08280B/cit54/1 publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2013.05.040 contributor: fullname: Miliovsky – volume: 106 volume-title: Theory of Orientation and Steroselection year: 1984 ident: D2RA08280B/cit72/1 contributor: fullname: Parr – volume: 5 start-page: 24094 year: 2015 ident: D2RA08280B/cit82/1 publication-title: RSC Adv. doi: 10.1039/C5RA02134K contributor: fullname: Petrović – volume: 22 start-page: 2080 year: 2014 ident: D2RA08280B/cit17/1 publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2014.02.042 contributor: fullname: Khalil – volume: 63 start-page: 8765 year: 2015 ident: D2RA08280B/cit76/1 publication-title: J. Agric. Food Chem. doi: 10.1021/acs.jafc.5b03839 contributor: fullname: Foti – volume: 856 start-page: 38 year: 2008 ident: D2RA08280B/cit66/1 publication-title: J. Mol. Struct. doi: 10.1016/j.theochem.2008.01.014 contributor: fullname: Antonczak – volume: 62 start-page: 4251 year: 2014 ident: D2RA08280B/cit71/1 publication-title: J. Agric. Food Chem. doi: 10.1021/jf500180u contributor: fullname: Xie |
| SSID | ssj0000651261 |
| Score | 2.4283588 |
| Snippet | The pyrazolone class comprises a variety of hybrid compounds displaying diverse biological actions. Although studied for decades, these compounds are still of... |
| SourceID | pubmedcentral proquest crossref pubmed |
| SourceType | Open Access Repository Aggregation Database Index Database |
| StartPage | 2884 |
| SubjectTerms | Antioxidants Catechol Chemistry Density functional theory Enthalpy Pyrazolones Scavenging Solvents |
| Title | Pyrazolone-type compounds (part II): in vitro and in silico evaluation of antioxidant potential; structure-activity relationship |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/36756409 https://www.proquest.com/docview/2769597242 https://www.proquest.com/docview/2774894839 https://pubmed.ncbi.nlm.nih.gov/PMC9846718 |
| Volume | 13 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9tAEB4RLvRSUaCteUSLyoEeTFg_4l04hQCCQxGCVurN8j4sLAXHchJEe6r4C_xDfgkzdhxIuXGyrVk_dma9M7M78w3ADrcplzoKXKMC6eKEp91EedqVMkSKFxodUr7z2XV08VscnxBMTtjkwlRB-1ple_ngdi_PbqrYyuJWd5o4sc7lj74kpclFpwUttA1fuej19Is6rMsbKFJfdoxXJoTUtq_mlc8bi_L_wMhXmuZ0GT5OTUTWqz_lEyzYfAWW-k1ltlV4uPxTJn9x1sqtS0uojOLCqTzSiO0W2AN2fv79gGU5u8vG5ZAluaGLUTZAqbMXeG82TJGGZ_eZwSMrhmMKHUoGh6xGlZ2U9unfI2U-UIEJVjZxczdZsQa_Tk9-9s_caS0FV6PKHru-CFRolDSRSCl_SatAGCsSI0RqrCWcL0-lZMBF5NHtc8WF0Ql5aNxKofzPsJhjt74CC40vrVDIUqEC43OV4iOxrYoMT33ZdeBbw-S4qCEz4mqr25fxsXfVq0Rx5MBmw_94-tuMYi_qSvRw0GxwYHtGRu7SLkaS2-GE2hBgToCGnQNfanHNXuOj-9NFj9WBaE6QswYEpj1PwTFWgWpPx9T6u-_cgA9Uip6WZ7jYhEUUlN2C1shM2pWj366G6TNn1fTL |
| link.rule.ids | 230,315,729,782,786,866,887,27933,27934,53800,53802 |
| linkProvider | National Library of Medicine |
| linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9tAEB6V9ACXvijUbVoW0UN7MMn6Ee_SEw2gRDyEWir1ZnkfFpaCYzlJ1fZU9S_wD_klzNhxSuiNk23Nev34dndmdme_AXjPbcqljgLXqEC6OOBpN1GedqUMUeKFRoe033nwNTr7Lg4OiSYnbPbCVEH7WmW7-ehqN88uq9jK4kp3mjixzvlpX5LS5KKzAo-xv3a7d5z0egBGLdbjDRmpLzvGKxPiauuqZfXzn015PzTyjq45evrAt3wGT-bGJduvxc_hkc1fwGq_yem2Dn_Pf5XJbxzvcuvS5CujiHJKrDRhHwqslQ2HH_dYlrMf2bQcsyQ3dDHJRthe2D9icDZOUYZnPzODR1aMpxR0lIw-sZqPdlbamz_XtGeCUlOwsom4u8yKl_Dt6PCiP3DnWRhcjcp-6voiUKFR0kQipZ1PWgXCWJEYIVJjLTGEeSol0y8iX7DLFRdGJ-TbcSuF8jegleNnvQIWGl9aoRAKoQLjc5VilVhWRYanvuw5sNOAExc12UZcLZL7Mj7wvuxXEH52oN3gFs873CT2op5E3wgNDge2F2L8u7T-keR2PKMyRLUToEnowGYN8-IxPjpOPfR1HYiWGsCiANFwL0sQ94qOe47z6wffuQWrg4vTk_hkeHb8BtYooT1N8nDRhhaCZt_CysTM3lWN_BYSzAl4 |
| linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEB71IQEXWt6mLSyCAxxcZ_2Id9tTSRo1AqqIh8TN8j6sWkody0kQ9FT1L_Qf8kuYsePQwA1OtrXj9ePb3ZnZnf0G4BW3GZc6Dl2jQunigKfdVPnalTLCEj8yOqL9zief4tOvon9MNDnLVF910L5W-X4xPt8v8rM6trI8114bJ-aNPvQkKU0uvNJk3jpsYp_t-Dcc9WYQRk3W5S0haSA941cp8bV11KoK-suu_DM88oa-GWz9x5tuw92FkcmOGpF7sGaL-3C71-Z2ewBXox9VeoHjXmFdmoRlFFlOCZam7HWJNbPh8M0Bywv2LZ9VE5YWhi6m-RjbDftNEM4mGZbh2ffc4JGVkxkFH6XjQ9bw0s4r-_PymvZOUIoKVrWRd2d5-RC-DI4_907cRTYGV6PSn7mBCFVklDSxyGgHlFahMFakRojMWEtMYb7KyASMySfscMWF0Sn5eNxKoYJHsFHgZz0BFplAWqEQDqFCE3CVYZUoq2LDs0B2HXjZApSUDelGUi-WBzLp-x-PahjfOrDbYpcsOt408eOuRB8JDQ8HXiyL8e_SOkha2MmcZIhyJ0TT0IHHDdTLxwToQHXR53UgXmkESwGi414tQexrWu4F1k__-c7ncGvUHyTvh6fvduAO5bWnuR4udmEDMbN7sD4182d1O_8FOucL-A |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pyrazolone-type+compounds+%28part+II%29%3A+in+vitro+and+in+silico+evaluation+of+antioxidant+potential%3B+structure%E2%80%93activity+relationship&rft.jtitle=RSC+advances&rft.au=Brankovi%C4%87%2C+Jovica&rft.au=Milovanovi%C4%87%2C+Vesna+M&rft.au=Petrovi%C4%87%2C+Zorica+D&rft.au=Simijonovi%C4%87%2C+Du%C5%A1ica&rft.date=2023-01-18&rft.pub=Royal+Society+of+Chemistry&rft.eissn=2046-2069&rft.volume=13&rft.issue=5&rft.spage=2884&rft.epage=2895&rft_id=info:doi/10.1039%2Fd2ra08280b&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2046-2069&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2046-2069&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2046-2069&client=summon |